CEST MRI of glucosamine uptake in brain tumor-bearing mice
Researchers have demonstrated that glucosamine-based CEST MRI can effectively detect and characterize brain tumors in mice. This non-radioactive imaging technique offers a potential biocompatible alternative to traditional FDG-PET scans for cancer metabolism monitoring.
Why it matters
This advancement could lead to safer, more accessible diagnostic tools for brain cancer imaging by utilizing a common dietary supplement as a contrast agent.
Scientific Reports ( 2026 ) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in